EPIRUS Biopharmaceuticals, Inc. Operating Expenses
EPIRUS Biopharmaceuticals, Inc. reported Operating Expenses of $16.81 million for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2016-05-10
- EPIRUS Biopharmaceuticals, Inc. operating expenses for the quarter ending 2016-03-31 was $16.81M, a 131.96% increase year-over-year.
- EPIRUS Biopharmaceuticals, Inc. operating expenses for the quarter ending 2015-12-31 was $16.31M, a 60.58% increase year-over-year.
- EPIRUS Biopharmaceuticals, Inc. operating expenses for the quarter ending 2015-09-30 was $14.26M, a 2.40% increase year-over-year.
- EPIRUS Biopharmaceuticals, Inc. operating expenses for the quarter ending 2015-06-30 was $15.06M, a 68.28% increase year-over-year.
- EPIRUS Biopharmaceuticals, Inc. operating expenses for fiscal 2015 was $52.88M, a 34.69% increase from fiscal 2014.
- EPIRUS Biopharmaceuticals, Inc. operating expenses for fiscal 2014 was $39.26M, a 171.35% increase from fiscal 2013.
- EPIRUS Biopharmaceuticals, Inc. operating expenses for fiscal 2013 was $14.47M, a 73.88% decline from fiscal 2012.
- EPIRUS Biopharmaceuticals, Inc. operating expenses for fiscal 2012 was $55.39M, a 8.95% increase from fiscal 2011.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-03-31 | $16.81M 10-Q · filed 2016-05-10 | $33.12M derived: sum of 2 quarters · filed 2016-05-10 | $47.39M derived: sum of 3 quarters · filed 2016-05-10 | $62.44M derived: sum of 4 quarters · filed 2016-05-10 | ||||
| 2015-12-31 | $16.31M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $30.58M derived: sum of 2 quarters · filed 2016-03-29 | $45.63M derived: sum of 3 quarters · filed 2016-03-29 | $52.88M 10-K · filed 2016-03-29 | ||||
| 2015-09-30 | $14.26M 10-Q · filed 2015-11-16 | $29.32M derived: sum of 2 quarters · filed 2015-11-16 | $36.56M 10-Q · filed 2015-11-16 | $46.73M derived: sum of 4 quarters · filed 2016-05-10 | ||||
| 2015-06-30 | $15.06M 10-Q · filed 2015-08-12 | $22.30M 10-Q · filed 2015-08-12 | $32.46M derived: sum of 3 quarters · filed 2016-05-10 | $46.39M derived: sum of 4 quarters · filed 2016-05-10 | ||||
| 2015-03-31 | $7.25M 10-Q · filed 2016-05-10 | $17.41M derived: sum of 2 quarters · filed 2016-05-10 | $31.34M derived: sum of 3 quarters · filed 2016-05-10 | $40.28M derived: sum of 4 quarters · filed 2016-05-10 | ||||
| 2014-12-31 | $10.16M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $24.09M derived: sum of 2 quarters · filed 2016-03-29 | $33.04M derived: sum of 3 quarters · filed 2016-03-29 | $39.26M 10-K · filed 2016-03-29 | ||||
| 2014-09-30 | $13.93M 10-Q · filed 2015-11-16 | $22.88M derived: sum of 2 quarters · filed 2015-11-16 | $29.10M 10-Q · filed 2015-11-16 | $42.05M derived: sum of 4 quarters · filed 2015-11-16 | ||||
| 2014-06-30 | $8.95M 10-Q · filed 2015-08-12 | $6.54M 10-Q · filed 2014-08-11 | $15.17M 10-Q · filed 2015-08-12 | $11.63M 10-Q · filed 2014-08-11 | $28.13M derived: sum of 3 quarters · filed 2015-08-12 | $31.15M derived: sum of 4 quarters · filed 2015-08-12 | ||
| 2014-03-31 | $6.22M 10-Q · filed 2015-05-13 | $5.09M 10-Q · filed 2014-05-09 | $19.18M derived: sum of 2 quarters · filed 2015-05-13 | $22.20M derived: sum of 3 quarters · filed 2015-05-13 | $36.29M derived: sum of 4 quarters · filed 2015-05-13 | |||
| 2013-12-31 | $12.96M 10-K · filed 2014-03-14 | $15.98M derived: sum of 2 quarters · filed 2014-11-10 | $30.07M derived: sum of 3 quarters · filed 2014-11-10 | $14.47M 10-K · filed 2015-03-31 | $51.94M 10-K · filed 2014-03-14 | |||
| 2013-09-30 | $3.03M 10-Q · filed 2014-11-10 | $13.60M 10-Q · filed 2013-11-04 | $17.11M derived: sum of 2 quarters · filed 2014-11-10 | $10.64M 10-Q · filed 2014-11-10 | $38.99M 10-Q · filed 2013-11-04 | $40.10M derived: sum of 4 quarters · filed 2014-11-10 | ||
| 2013-06-30 | $14.08M 10-Q · filed 2014-08-11 | $25.39M 10-Q · filed 2014-08-11 | $37.08M derived: sum of 3 quarters · filed 2014-08-11 | $52.28M derived: sum of 4 quarters · filed 2014-08-11 | ||||
| 2013-03-31 | $11.30M 10-Q · filed 2014-05-09 | $22.99M derived: sum of 2 quarters · filed 2014-03-14 | $38.20M derived: sum of 3 quarters · filed 2014-03-14 | $51.37M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-12-31 | $11.69M 10-K · filed 2014-03-14 | $26.90M derived: sum of 2 quarters · filed 2014-03-14 | $40.07M derived: sum of 3 quarters · filed 2014-03-14 | $55.39M 10-K · filed 2014-03-14 | ||||
| 2012-09-30 | $15.21M 10-K · filed 2014-03-14 | $28.38M derived: sum of 2 quarters · filed 2014-03-14 | $43.70M 10-Q · filed 2013-11-04 | $56.97M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-06-30 | $13.17M 10-K · filed 2014-03-14 | $28.49M 10-Q · filed 2013-08-05 | $41.76M derived: sum of 3 quarters · filed 2014-03-14 | $54.48M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-03-31 | $15.32M 10-K · filed 2014-03-14 | $28.59M derived: sum of 2 quarters · filed 2014-03-14 | $41.31M derived: sum of 3 quarters · filed 2014-03-14 | $54.31M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2011-12-31 | $13.27M 10-K · filed 2013-03-07 | $25.99M derived: sum of 2 quarters · filed 2013-03-07 | $38.99M derived: sum of 3 quarters · filed 2013-03-07 | $50.84M 10-K · filed 2014-03-14 | ||||
| 2011-09-30 | $12.72M 10-K · filed 2013-03-07 | $25.72M derived: sum of 2 quarters · filed 2013-03-07 | $37.56M 10-Q · filed 2012-11-08 | $51.05M derived: sum of 4 quarters · filed 2013-03-07 | ||||
| 2011-06-30 | $13.00M 10-K · filed 2013-03-07 | $24.84M 10-Q · filed 2012-08-07 | $38.34M derived: sum of 3 quarters · filed 2013-03-07 | $50.91M derived: sum of 4 quarters · filed 2013-03-07 | ||||
| 2011-03-31 | $11.85M 10-K · filed 2013-03-07 | $25.34M derived: sum of 2 quarters · filed 2013-03-07 | $37.91M derived: sum of 3 quarters · filed 2013-03-07 | $49.78M derived: sum of 4 quarters · filed 2013-03-07 | ||||
| 2010-12-31 | $13.49M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $26.06M derived: sum of 2 quarters · filed 2013-03-07 | $37.94M derived: sum of 3 quarters · filed 2013-03-07 | $53.86M 10-K · filed 2013-03-07 | ||||
| 2010-09-30 | $12.57M 10-Q · filed 2011-11-04 | $24.44M derived: sum of 2 quarters · filed 2011-11-04 | $40.37M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $11.87M 10-Q · filed 2011-08-04 | $27.80M 10-Q · filed 2011-08-04 | ||||||
| 2009-12-31 | $37.88M 10-K · filed 2012-03-09 |